Imaging of Brain Tumors with Copper-64 Chloride: Early Experience and Results-Reference-Cited by-同舟云学术

Imaging of Brain Tumors with Copper-64 Chloride: Early Experience and Results

Published:2016-06 Issue:5 Volume:31 Page:159-167
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Panichelli Paola¹,Villano Carlo²,Cistaro Angelina³,Bruno Andrea⁴,Barbato Francesco⁵,Piccardo Arnoldo⁶,Duatti Adriano⁷

Affiliation:

1. Advanced Center of Oncology, ACOM, Macerata, Italy.

2. Hospital “Santo Spirito,” Pescara, Italy.

3. Positron Emission Tomography Centre, IRMET, Affidea, Turin, Italy.

4. ASST “Papa Giovanni XXIII,” Bergamo, Italy.

5. CMO Center, Naples, Italy.

6. Ospedali Galliera, Genoa, Italy.

7. Department of Chemical and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2016.2028

Reference38 articles.

1. Central nervous system

2. Low-Grade Glioma

3. Glioma Biology and Molecular Markers

4. Epidemiology of Gliomas

5. Current Status of Hybrid PET/MRI in Oncologic Imaging

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidental Detection of Second Primary Thyroid Malignancy in Patients of Metastatic Castration-Resistant Prostate Carcinoma;Clinical Nuclear Medicine;2024-05-14

2. Unveiling the promising anticancer effect of copper-based compounds: a comprehensive review;Journal of Cancer Research and Clinical Oncology;2024-04-25

3. Cuproptosis in glioblastoma: unveiling a novel prognostic model and therapeutic potential;Frontiers in Oncology;2024-03-28

4. Evaluation of the theranostic potential of [64Cu]CuCl2 in glioblastoma spheroids;EJNMMI Research;2024-03-07

5. Polymer–Drug Conjugates Codeliver a Temozolomide Intermediate and Nitric Oxide for Enhanced Chemotherapy against Glioblastoma Multiforme;ACS Applied Bio Materials;2024-02-26